Epidemiology of cardiovascular disease

[1]  Charles E. McCulloch,et al.  CHRONIC KIDNEY DISEASE AND THE RISKS OF DEATH, CARDIOVASCULAR EVENTS, AND HOSPITALIZATION , 2004 .

[2]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[3]  R. Tracy,et al.  Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. , 1998, The New England journal of medicine.

[4]  P. Ridker.  C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. , 2007, Journal of the American College of Cardiology.

[5]  J. Manson,et al.  Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. , 2004, JAMA.

[6]  A. Go,et al.  Statin and -Blocker Therapy and the Initial Presentation of Coronary Heart Disease , 2006, Annals of Internal Medicine.

[7]  S. Olshansky,et al.  The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases. , 1986, The Milbank quarterly.

[8]  I. Darnton-Hill,et al.  A global response to a global problem: the epidemic of overnutrition. , 2002, Bulletin of the World Health Organization.

[9]  P. Libby,et al.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.

[10]  V. Salomaa,et al.  Changes in premature deaths in Finland: successful long-term prevention of cardiovascular diseases. , 1998, Bulletin of the World Health Organization.

[11]  James D. Neaton,et al.  Serum Cholesterol, Blood Pressure, Cigarette Smoking, and Death From Coronary Heart Disease Overall Findings and Differences by Age for 316099 White Men , 1992 .

[12]  H. Adachi,et al.  Trends in Nutritional Intake and Serum Cholesterol Levels over 40 Years in Tanushimaru, Japanese Men , 2005, Journal of epidemiology.

[13]  Robert L Hanson,et al.  Components of the "metabolic syndrome" and incidence of type 2 diabetes. , 2002, Diabetes.

[14]  Jesús Santos,et al.  Peripheral arterial disease in HIV patients older than 50 years of age. , 2008, AIDS research and human retroviruses.

[15]  N J Wald,et al.  Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence , 1997, BMJ.

[16]  C. Lamendola,et al.  Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group IV: lifestyle and medical management of risk factors. , 2002, Circulation.

[17]  Paul Hjemdahl.  Stress and the metabolic syndrome: an interesting but enigmatic association. , 2002, Circulation.

[18]  R. D'Agostino,et al.  Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. , 1997, American journal of epidemiology.

[19]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[20]  A. Dyer,et al.  Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events , 2003 .

[21]  N. Benowitz.  Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. , 2003, Progress in cardiovascular diseases.

[22]  Deepak L. Bhatt,et al.  Ethnic differences in cardiovascular risks and mortality in atherothrombotic disease: insights from the Reduction of Atherothrombosis for Continued Health (REACH) registry. , 2011, Mayo Clinic proceedings.

[23]  W. Wolfe,et al.  Overweight school children in New York City: prevalence estimates and characteristics , 1998, International Journal of Obesity.

[24]  F. Epstein.  Cardiovascular disease epidemiology: a journey from the past into the future. , 1996, Circulation.

[25]  J. Gaziano.  Fifth phase of the epidemiologic transition: the age of obesity and inactivity. , 2010, JAMA.

[26]  W. Kannel,et al.  Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. , 1961, Annals of internal medicine.

[27]  K. Flegal,et al.  Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. , 2004, JAMA.

[28]  P. Ridker.  C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease. , 2009, Clinical chemistry.

[29]  Tebeb Gebretsadik,et al.  Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. , 2005, Arthritis and rheumatism.

[30]  Stanton A. Glantz,et al.  Cardiovascular Effects of Secondhand Smoke: Nearly as Large as Smoking , 2005, Circulation.

[31]  Eric M. Isselbacher,et al.  Thoracic and Abdominal Aortic Aneurysms , 2005, Circulation.

[32]  Bernard J. Gersh,et al.  Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention , 2007, Circulation.

[33]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .

[34]  L. Groop,et al.  Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.

[35]  K. Flegal,et al.  Prevalence of overweight among preschool children in the United States, 1971 through 1994. , 1997, Pediatrics.

[36]  Goutham Rao,et al.  Childhood Obesity and Type 2 Diabetes Mellitus , 2005, Pediatrics.

[37]  S. Reis,et al.  Metabolic Syndrome Modifies the Cardiovascular Risk Associated With Angiographic Coronary Artery Disease in Women: A Report From the Women’s Ischemia Syndrome Evaluation , 2004, Circulation.

[38]  P. Whelton,et al.  Trends in blood pressure among children and adolescents. , 2004, JAMA.

[39]  A. Rodgers,et al.  Global burden of blood-pressure-related disease, 2001 , 2008, The Lancet.

[40]  B. Astor,et al.  The Association Between A1C and Subclinical Cardiovascular Disease , 2009, Diabetes Care.

[41]  S. Yusuf,et al.  Dietary Patterns and the Risk of Acute Myocardial Infarction in 52 Countries: Results of the INTERHEART Study , 2008, Circulation.

[42]  A J Dobson,et al.  Current smoking and the risk of non-fatal myocardial infarction in the WHO MONICA Project populations , 2004, Tobacco Control.

[43]  E. Simonson,et al.  Coronary Heart Disease among Minnesota Business and Professional Men Followed Fifteen Years , 1963, Circulation.

[44]  T. Welborn,et al.  Central obesity and multivariable cardiovascular risk as assessed by the Framingham prediction scores. , 2009, The American journal of cardiology.

[45]  Roberto Torella,et al.  Glucose metabolism and coronary heart disease in patients with normal glucose tolerance. , 2004, JAMA.

[46]  Ling Zheng,et al.  Sex-specific trends in midlife coronary heart disease risk and prevalence. , 2009, Archives of internal medicine.

[47]  Judith Wylie-Rosett,et al.  Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. , 2009, Circulation.

[48]  H. Blackburn.  20th-Century “medical Marco Polos” in the origins of preventive cardiology and cardiovascular disease epidemiology. , 2012, The American journal of cardiology.

[49]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[50]  M. Thun,et al.  Epidemiologic studies of fatal and nonfatal cardiovascular disease and ETS exposure from spousal smoking. , 1999, Environmental health perspectives.

[51]  W. Kannel,et al.  Menopause and Coronary Heart Disease: The Framingham Study , 1978 .

[52]  J. Kaski,et al.  C-reactive protein elevation and disease activity in patients with coronary artery disease. , 2004, European heart journal.

[53]  S. Lévesque,et al.  Incidence and clinical characteristics of the metabolic syndrome in patients with coronary artery disease , 2003, Coronary artery disease.

[54]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[55]  W H Dietz,et al.  The continuing epidemic of obesity in the United States. , 2000, JAMA.

[56]  E. Vartiainen,et al.  Twenty-year trends in coronary risk factors in north Karelia and in other areas of Finland. , 1994, International journal of epidemiology.

[57]  Asaf Bitton,et al.  Growing epidemic of coronary heart disease in low- and middle-income countries. , 2010, Current problems in cardiology.

[58]  A. LaCroix,et al.  The prediction of midlife coronary heart disease and hypertension in young adults: the Johns Hopkins multiple risk equations. , 1990, American journal of preventive medicine.

[59]  E. Mervaala,et al.  Sodium intake and hypertension. , 2006, Progress in cardiovascular diseases.

[60]  W. Kannel,et al.  Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. , 1986, American heart journal.

[61]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2008. , 2010, JAMA.

[62]  Per Magne Ueland,et al.  Homocysteine lowering and cardiovascular events after acute myocardial infarction. , 2006, The New England journal of medicine.

[63]  Laura Kettel Khan,et al.  Trends and correlates of class 3 obesity in the United States from 1990 through 2000. , 2002, JAMA.

[64]  C. Caspersen,et al.  Physical activity and the incidence of coronary heart disease. , 1987, Annual review of public health.

[65]  J. Gerberding,et al.  Actual causes of death in the United States, 2000. , 2004, JAMA.

[66]  W. Willett,et al.  The public health and economic benefits of taxing sugar-sweetened beverages. , 2009, The New England journal of medicine.

[67]  Paul M Ridker,et al.  Inflammation in atherosclerosis: from pathophysiology to practice. , 2009, Journal of the American College of Cardiology.

[68]  M. Sani.  Myocardial disease in human immunodeficiency virus (HIV) infection: a review , 2008, Wiener klinische Wochenschrift.